DCIS (Ductal carcinoma in situ) – should we call it a cancer?
نویسندگان
چکیده
منابع مشابه
Ductal carcinoma in situ (DCIS) in Karachi.
OBJECTIVE To study the frequency of ductal carcinoma in situ (DCIS) in a large pathology series. DCIS is a proliferation of non-invasive, malignant epithelial cells within the ductolobular system of the breast. It is a heterogeneous entity with several morphologic variants that differ in gross appearance, growth pattern, cytologic features, mammography, and malignant potential. METHODS The da...
متن کاملDiagnosis and management of ductal carcinoma in situ (DCIS).
OBJECTIVES Systematic synthesis of the published evidence about incidence, risk factors, and management options for women with ductal carcinoma in situ (DCIS) of the breast. DATA SOURCES Original epidemiologic studies were sought from several databases to identity articles published in English between 1970 and January 31, 2009. REVIEW METHODS Incidence of DCIS in the general population and ...
متن کاملLow grade Ductal Carcinoma in situ (DCIS): how best to describe it?
BACKGROUND In the absence of definitive data about the natural history of DCIS the appropriateness of describing DCIS as cancer is controversial. METHODS We conducted a survey amongst British Breast Group (BBG) members, to determine which descriptions of DCIS were deemed most accurate and appropriate. RESULTS 54/73 (74%) attendees completed the survey: A majority (34/54; 63%) said they woul...
متن کاملDuctal carcinoma in situ: should the name be changed?
S peakers at the National Institutes of Health state-of-the-science conference on ductal carcinoma in situ (DCIS) in September set out to assess critical areas in the field and ended up with a range of research recommendations: Improve risk stratification of patients, look closer at biomarkers, and compare the effectiveness of treatment methods. Surprisingly, though, after an unexpected fl urry...
متن کاملThe management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
Lobular carcinoma in situ was first described over 60 years ago. Despite the long history, it continues to pose significant difficulties in screening, diagnosis, management and treatment. This is partly due its multi-focal and bilateral presentation, an incomplete understanding of its biology and natural history and perpetuation of misconceptions gathered over the last decades. In this review, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Complementary & Alternative Medicine
سال: 2018
ISSN: 2381-1803
DOI: 10.15406/ijcam.2018.11.00377